Blocking connexin 43 accelerates corneal healing and improves tissue remodeling during the healing of diabetic rat corneas: A histological and immunohistochemical study

• Published in: European journal of inflammation 2019-04, Vol.17
• Main Authors: Elbadawy, Hossein M, Elshawarby, Amany, Raafat, Mona H, Bahaa, Nevine, Abdul, Mohi IM, Aljuhani, Naif, Bahashwan, Saleh, Eltahir, Heba M, Albarry, Maan, Parekh, Mohit, Ferrari, Stefano
• Format: Article
• Language: English
• Subjects: Cornea; Diabetes; Rodents; Wound healing
• ISSN: 2058-7392; 1721-727X; 2058-7392
• DOI: 10.1177/2058739219843389

Connexin 43 (Cx43) is a potential target for accelerating wound healing. This study aimed at evaluating the therapeutic efficiency of topical application of Gap27, a Cx43 mimetic peptide, on corneal tissue reorganization during wound healing in streptozocin-induced Diabetes in albino rats and its effect on the infiltration of inflammatory cells. Fifty adult male albino Wistar rats were divided equally into two groups: non-diabetic and diabetic. Twenty rats from each group were subjected to corneal injury: 10 untreated and 10 treated with Gap27. The remaining five rats from each group served as negative controls (intact corneas). All rats were sacrificed 3 days after injury. Histological studies were performed to assess signs of cell degeneration, the infiltration of inflammatory cells. Histomorphometric studies were performed to quantify the expression of Cx43. Gap27 promoted corneal wound healing in non-diabetic and diabetic rats. It reduced mononuclear cell infiltration and improved corneal tissue remodeling. However, minor structural changes were still seen in diabetic corneas after treatment with Gap27. Blocking Cx43 was a valuable tool to restore corneal tissue structure, reduce the infiltration of inflammatory cells in non-diabetic and diabetic rats.